The GLP is committed to full transparency. Download and review our Annual Report.

Articles written for the GLP list the source as Genetic Literacy Project. All other articles were written for the sources noted with excerpts provided by the GLP.
4-9-2019 fda approves nasal spray antidepressant spravato gupta pkg newday vpx exlarge

Why esketamine will force doctors to rethink office visits for depressed patients

STAT | 
The Food and Drug Administration approved esketamine (Spravato) for treatment-resistant depression to be administered under physician supervision. It’s a derivative of ...